Ursodeoxycholic Acid Oral Suspension 125 mg/5 ml (60 ml)

Ursodeoxycholic Acid 125 mg/5 ml suspension provides gentle and effective care for comprehensive liver wellness. Formulated to enhance bile secretion, protect liver cells from toxic bile acids, and support digestion, this oral suspension is indicated for primary biliary cholangitis, gallstone dissolution, and cholestatic liver conditions. Supplied in a safe 60 ml PET bottle complete with an accurate dosing measuring cup.

Ursodeoxycholic Acid Oral Suspension 125 mg/5 ml (60 ml) is a hepatobiliary pharmaceutical formulation containing Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid used for the management of certain liver and biliary tract conditions. It works by modifying the composition of bile, reducing the proportion of cholesterol in bile, and supporting the flow of bile from the liver into the intestine. These actions may help reduce cholesterol saturation in bile and promote the dissolution of selected small cholesterol gallstones in appropriately selected patients. Ursodeoxycholic Acid is also prescribed for certain cholestatic liver disorders, including primary biliary cholangitis, according to the patient's clinical condition and approved treatment guidelines. By supporting bile flow and reducing the potentially harmful effects of some bile acids on liver cells, it may help improve certain liver-related biochemical markers in suitable patients. The 125 mg/5 ml concentration and 60 ml bottle pack provide a liquid dosage form that may be useful for patients who have difficulty swallowing tablets, including children when the medicine is specifically prescribed for an appropriate indication. The required dose and treatment duration depend on the patient's body weight, diagnosis, liver function, and response to treatment. Possible side effects include diarrhoea, nausea, abdominal discomfort, and changes in bowel habits. Ursodeoxycholic Acid is not suitable for every type of gallstone or liver disease, and gallstones may require imaging and specialist assessment before treatment. Patients with biliary obstruction, acute inflammation of the gallbladder or bile ducts, or other significant hepatobiliary conditions require medical evaluation before use. Regular monitoring of liver function and, where appropriate, ultrasound examinations may be recommended during treatment. Ursodeoxycholic Acid Oral Suspension 125 mg/5 ml (60 ml) should be used only under medical supervision, with the dosage determined by a qualified healthcare professional according to the confirmed diagnosis and the product's approved prescribing information.